Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (3) , 458-464
- https://doi.org/10.1016/s0272-6386(00)70198-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- In Vitro Metabolism of the Vitamin D Analog, 22-Oxacalcitriol, Using Cultured Osteosarcoma, Hepatoma, and Keratinocyte Cell LinesPublished by Elsevier ,1996
- Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary studyNephrology Dialysis Transplantation, 1996
- The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.Endocrinology, 1993
- Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidismKidney International, 1993
- Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patientsBone, 1993
- 22-oxacalcitriol suppresses 25-hydroxycholecalciferol-1α-hydroxylase in rat kidneyBiochemical and Biophysical Research Communications, 1992
- The Activity of 22-Oxacalcitriol in Osteoblast-Like (ROS 17/2.8) Cells*Endocrinology, 1991
- The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.Journal of Clinical Investigation, 1989
- Osteocalcin and bone morphometric parameters in adults without bone diseaseCalcified Tissue International, 1988
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987